Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 108, Issue 9, Pages 3749-3754
Publisher
Proceedings of the National Academy of Sciences
Online
2011-02-15
DOI
10.1073/pnas.1014480108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A reproducible brain tumour model established from human glioblastoma biopsies
- (2010) Jian Wang et al. BMC CANCER
- Nestin expression in astrocytic tumors delineates tumor infiltration
- (2010) Ryuhei Kitai et al. Brain Tumor Pathology
- Bevacizumab and Recurrent Malignant Gliomas: A European Perspective
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Glioblastoma stem-like cells give rise to tumour endothelium
- (2010) Rong Wang et al. NATURE
- Metabolic Modulation of Glioblastoma with Dichloroacetate
- (2010) E. D. Michelakis et al. Science Translational Medicine
- Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
- (2009) Divya Pathania et al. ADVANCED DRUG DELIVERY REVIEWS
- Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
- (2009) Joost JC Verhoeff et al. BMC CANCER
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy
- (2009) A. K. Lucio-Eterovic et al. CLINICAL CANCER RESEARCH
- Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms
- (2009) Hrvoje Miletic et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffusion Magnetic Resonance Imaging Detects Pathologically Confirmed, Nonenhancing Tumor Progression in a Patient With Recurrent Glioblastoma Receiving Bevacizumab
- (2009) Elizabeth R. Gerstner et al. JOURNAL OF CLINICAL ONCOLOGY
- iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
- (2009) Uros Rajcevic et al. MOLECULAR & CELLULAR PROTEOMICS
- EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
- (2009) Haitao Ji et al. MOLECULAR CELL
- Biomarkers of response and resistance to antiangiogenic therapy
- (2009) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Antiangiogenic therapies for high-grade glioma
- (2009) Andrew D. Norden et al. Nature Reviews Neurology
- Cancer stem cells and angiogenesis
- (2009) Rolf Bjerkvig et al. SEMINARS IN CANCER BIOLOGY
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy
- (2008) David A Reardon et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
- (2008) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics
- (2008) Frits Thorsen et al. NMR IN BIOMEDICINE
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now